GLP-1 Therapy for Weight Loss, Appetite Control and Metabolic Health
Clinically-studied Semaglutide and Tirzepatide prescribed by licensed physicians, delivered to your door.
Discount auto-applied at checkout
Discount auto-applied at checkout
How GLP-1 Therapy Works
1
Eligibility Quiz
Take a short quiz covering your health and medical history.
2
Provider Evaluation
A licensed physician reviews your info and determines a personalized treatment plan and prescription if appropriate.
3
Free Delivery
If prescribed, a U.S.-based state-licensed compounding pharmacy ships your medication directly to you for free.
Clinically Studied GLP-1 Therapy Backed by Published Research
Mayo Clinic classifies semaglutide as a GLP-1 receptor agonist, a medicine that works with your body's own appetite and blood-sugar signals instead of overriding them. It's proven to support real, lasting weight loss in adults with a weight-related health condition, when used alongside healthier eating and regular movement.
In the landmark STEP 1 trial published in the New England Journal of Medicine and indexed by the National Library of Medicine — adults taking semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks, versus just 2.4% on placebo.
A 2026 review in the peer-reviewed journal Healthcare (MDPI) describes tirzepatide as a "dual" agonist — it engages two gut-hormone pathways, GIP and GLP-1, instead of just one. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, patients on the highest studied dose lost an average of 22.5% of their body weight over 72 weeks … More than one-fifth of their starting weight.
Source References
- Mayo Clinic. "Semaglutide (Subcutaneous Route) – Description and Side Effects." mayoclinic.org
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med. 2021;384(11):989-1002. (PMID: 33567185)
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387(3):205-216. (PMID: 35658024)
- "A Narrative Review of the Metabolic Benefits of GLP-1 and GIP Receptor Agonists in Obesity." Healthcare (Basel). 2026;14(6):734. (PMID: 41897188)
Take back control of your appetite
It's not willpower! It's biology. Physician-guided semaglutide and tirzepatide, personalized to your body and managed every step of the way.
Is GLP-1 therapy right for you?
What to expect
Appetite noticeably quiets within the first couple of weeks. Mild GI side effects, if any, typically begin to fade for most patients.
Dose increases on a personalized schedule, as weight loss loss starts to pick up pace.
Body shifts become visible. Here is where most patients hit milestones like coming down a full clothing size or losing 20+ pounds.
At your maintenance dose, metabolic markers like A1C, blood pressure, triglycerides frequently improve alongside weight.
Why GLP-1s?
* Individual results vary. Average outcomes from clinical literatureor chronic weight management. Individual results vary based on starting weight, adherence, dose, and lifestyle. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
GLP-1 Injections
Semaglutide — starting at $149 per month
Tirzepatide — starting at $179 per month
The Science Behind Semaglutide
Semaglutide belongs to the GLP-1 receptor agonist class — the same category of medication behind Ozempic® and Wegovy®. Rather than relying on willpower, it works through four distinct pathways in the body that govern hunger, fullness, and how you use energy.
Quiets appetite signals in the brain
Semaglutide mimics GLP-1, a hormone your gut releases naturally after eating. It signals fullness directly to the hypothalamus — the region of the brain that governs hunger and reward — which is often what quiets the constant mental pull toward food, sometimes described as "food noise."
Slows how quickly your stomach empties
With digestion paced more gradually, fullness sets in sooner and lasts longer between meals. Portions that once felt small start to feel satisfying, without the constant willpower struggle most diets demand.
Improves your body's insulin response
When blood sugar rises, semaglutide helps your body release insulin more efficiently and keeps glucagon in check — supporting steadier energy throughout the day and fewer of the post-meal crashes that tend to trigger snacking.
Helps results hold over time
Unlike short-term appetite suppressants, semaglutide addresses the underlying biology behind weight regulation — which is what makes it possible to sustain progress long-term when paired with consistent nutrition and movement.
We help people discover and then become the ideal version of themselves.
A well-functioning body is key to overall well-being, and access to evidence-based care empowers people to optimize their health and vitality. We democratize access to physician-guided treatments that support people in achieving their health goals, helping them feel and perform at their best.”
Frequently Asked Questions
Everything you need to know about GLP-1 therapy and the Meds.you program.
How does the GLP-1 treatment program work?
It starts with an online medical intake, followed by checkout, where your card is authorized but not yet charged.
Once your provider reviews and approves treatment, you're charged and your medication is sent to the pharmacy.
Your medication ships within 2 days with everything included: syringes, swabs, and instructions.
You'll self-administer at home, with unlimited provider messaging for guidance whenever you need it.
Do you charge extra for higher doses?
Our monthly plans are flat-rate and already include access to every dose tier.
Your provider will help determine the dose that's safest and most effective for your goals.
Who's a good candidate for GLP-1 treatment?
GLP-1 medications like semaglutide and tirzepatide are typically a fit if you're looking to lose weight, curb appetite, support healthier blood sugar levels, or improve your metabolic health long-term.
A licensed physician reviews your health history to determine whether semaglutide or tirzepatide is a safe, appropriate option for you.
What kind of weight loss results can I expect?
In the STEP-1 clinical trial, semaglutide produced an average body weight reduction of approximately 14.9% at 68 weeks among adults with obesity, compared to 2.4% on placebo. Results vary based on starting weight, adherence, dose, and lifestyle factors. Most patients begin seeing noticeable changes within the first 4–8 weeks.
In the SURMOUNT-1 clinical trial, tirzepatide produced an average body weight reduction of approximately 22.5% at 72 weeks among adults with obesity at the 15mg dose, compared to 2.4% on placebo. As with semaglutide, individual results depend on starting weight, adherence, dose, and lifestyle factors, with most patients noticing changes within the first 4–8 weeks.
What side effects should I know about?
The most common side effects with GLP-1 medications are:
- Nausea
- Diarrhea
- Vomiting
- Constipation
These are usually mild and short-lived. If you experience any discomfort, your doctor may adjust your dosing schedule or recommend ways to help manage it.
Who shouldn't take GLP-1s?
GLP-1 medications aren't recommended if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They're also not advised during pregnancy or breastfeeding, or for patients with severe gastrointestinal disease, a history of pancreatitis, or type 1 diabetes. Your physician will go over your complete health history to confirm what's safe for you.
How soon will I get my first shipment?
Once your physician approves your prescription (typically within 24 hours of intake), the compounding pharmacy ships it within 2–3 business days via expedited carrier. Most patients receive their first dose within 3–5 days of completing intake.
Get in Touch with us
We’re here to help anytime
Call Us
Mail Us
Opening Time
Mon -Sat: 7:00 - 17:00
Medicine, Treated Like It Matters.
Compounded Medication Disclosure: Compounded medications are personalized formulations prepared by licensed U.S. 503A or 503B compounding pharmacies under a physician's prescription. These medications are not FDA-approved and are only prescribed when a physician determines that a commercially available, FDA-approved product does not adequately meet the patient's needs. The decision to prescribe compounded medication is made solely by your licensed physician.
Trademark Disclaimer: Ozempic® and Wegovy® are registered trademarks owned by Novo Nordisk A/S. Zepbound®, KwikPen®, and LillyDirect™ are trademarks of Eli Lilly and Company. meds.you is an independently operated telehealth provider and is not sponsored, endorsed, or affiliated with Novo Nordisk A/S or Eli Lilly and Company
© Copyright 2026 meds.you Holdings, LLC. All Rights Reserved.